Apolipoprotein E genotype and the cardiovascular disease risk phenotype: Impact of sex and adiposity (the FINGEN study)

Atherosclerosis

Volumn 221, Issue 2, 2012, Pages 467-470

  Kofler, Bettina M ^a   Miles, Elizabeth A ^b   Curtis, Peter ^c,e   Armah, Christopher K ^a   Tricon, Sabine ^b   Grew, Jilly ^a   Napper, Frances L ^b   Farrell, Leslie ^d   Lietz, Georg ^c   Packard, Christopher J ^d   Caslake, Muriel J ^d   Mathers, John C ^c   Williams, Christine M ^a   Calder, Philip C ^b   Minihane, Anne Marie ^a,e  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Apolipoprotein E genotype; BMI; Cardiovascular; CRP; Inflammation; Lipids; Sex

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PADGEM PROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); DIET RESTRICTION; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE;

ADIPOSITY; ADULT; AGE FACTORS; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CELL ADHESION MOLECULES; CHOLESTEROL; CHOLESTEROL, LDL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; INFLAMMATION MEDIATORS; LINEAR MODELS; MALE; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES;

EID: 84858705828     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.01.042     Document Type: Article

References (15)

1. Bennet A.M., Di Angelantonio E., Ye Z., et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007, 298:1300-1311.
2. Song Y., Stampfer M.J., Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 2004, 141:137-147.
3. Wilson P.W., Schaefer E.J., Larson M.G., Ordovas J.M. Apolipoprotein E alleles and risk of coronary disease A meta-analysis. Arterioscler Thromb Vasc Biol 1996, 16:1250-1255.
4. Humphries, Talmud S.E., Hawe P.J., et al. E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet 2001, 358:115-119.
5. Yu H., Zhang W., Yancey P.G., et al. Macrophage apolipoprotein E reduces atherosclerosis and prevents premature death in apolipoprotein E and scavenger receptor-class BI double-knockout mice. Arterioscler Thromb Vasc Biol 2006, 26:150-156.
6. Jofre-Monseny L., Loboda A., Wagner A.E., et al. Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression. Biochem Biophys Res Commun 2007, 357:319-324.
7. Caslake M.J., Miles E.A., Kofler B.M., et al. Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr 2008, 88:618-629.
8. Anderson K.M., Odell P.M., Wilson P.W., Kannel W.B. Cardiovascular disease risk profiles. Am Heart J 1991, 121:293-298.
9. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005, 91(Suppl. 5):v1-v52.
10. Ingelsson E., Schaefer E.J., Contois J.H., et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 2007, 298:776-785.
11. Frikke-Schmidt R., Tybjaerg-Hansen A., Steffensen R., Jensen G., Nordestgaard B.G. Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: the Copenhagen City Heart Study. J Am Coll Cardiol 2000, 35:1192-1199.
12. Elosua R., Ordovas J.M., Cupples L.A., et al. Association of APOE genotype with carotid atherosclerosis in men and women: the Framingham Heart Study. J Lipid Res 2004, 45:1868-1875.
13. Buckley D.I., Fu R., Freeman M., Rogers K., Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U S. Preventive Services Task Force. Ann Intern Med 2009, 151:483-495.
14. Marz W., Scharnagl H., Hoffmann M.M., Boehm B.O., Winkelmann B.R. The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study). Eur Heart J 2004, 25:2109-2119.
15. Kaptoge S., Di Angelantonio E., et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375:132-140. Emerging Risk Factor Collaboration.